Țară: Israel
Limbă: engleză
Sursă: Ministry of Health
DACARBAZINE AS CITRATE
TZAMAL BIO-PHARMA LTD
L01AX04
POWDER FOR SOLUTION FOR INJ/INF
DACARBAZINE AS CITRATE 1000 MG/VIAL
I.V
Required
MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH, GERMANY
DACARBAZINE
Decarbazine is indicated for the treatment of patients with metastatic malignant melanoma. Further indications for dacarbazine as part of a combination chemotherapy in advanced Hodgkin's disease as a second line.
2015-02-17
העדוה לע הרמחה ( עדימ ןולעב )תוחיטב אפורל ךיראת רושיא ןולעה : 27.11.2016 םש רישכתה תילגנאב רפסמו םושירה DACARBAZINE MEDAC 200 MG (31170) DACARBAZINE MEDAC 500 MG (31171) DACARBAZINE MEDAC 1000 MG (31172) םש לעב םושירה TZAMAL BIO-PHARMA LTD . !דבלב תורמחהה טורפל דעוימ הז ספוט תושקובמה תורמחהה ןולעב קרפ יחכונ טסקט שדח טסקט ADVERSE EVENTS --- Infections and infestations Uncommon (>1/1,000, <1/100) Infections Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form at the following link : https://forms.gov.il/globaldata/getsequence/getsequence. spx?formType=AdversEffectMedic@moh.gov.il In addition, you may report by sending an e-mail message to safety@tzamal-medical.co.il or by visiting the "Contact Us" webpage at: http://www.tzamal-medical.co.il/69601.html or by phone: +972-73-7151107 ב"צמ ןולעה ובש םינמוסמ תורמחהה תושקובמה לע עקר בוהצ . דומע 1 ךותמ 1 BPS-Safety update form SPC-01 Citiți documentul complet